Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States.
J Hepatol. 2013 Nov;59(5):957-63. doi: 10.1016/j.jhep.2013.07.004. Epub 2013 Jul 10.
BACKGROUND & AIMS: Interferon treatment for chronic hepatitis C is associated with non-specific symptoms including fever. We aimed to determine the association of temperature changes with interferon antiviral activity.
60 treatment-naïve patients with chronic hepatitis C (67% genotype 1/4/6, 33% genotype 2/3) were admitted to start peginterferon alfa-2a and ribavirin in a clinical trial. Temperature was measured at baseline and 3 times daily for the first 24h and the maximal increase from baseline during that time (ΔTmax) was determined. Serum HCV-RNA, interferon-gamma-inducible protein-10 (IP-10) and expression of interferon-stimulated genes (ISGs - CD274, ISG15, RSAD2, IRF7, CXCL10) in peripheral blood mononuclear cells (PBMCs) were measured at very early time points, and response kinetics calculated. The IL28B single nucleotide polymorphism, rs12979860, was genotyped.
Temperatures rose by 1.2±0.8°C, peaking after 12.5h. ΔTmax was strongly associated with 1st phase virological decline (r=0.59, p<0.0001) and was independent of gender, cirrhosis, viral genotype or baseline HCV-RNA. The association with 1st phase decline was seen in patients with rs12979860CC genotype (r = 0.65, p <0.0001) but not in CT/TT (r = 0.13, p = 0.53) and patients with CC genotype had a higher DTmax (1.4 ± 0.8 C vs. 0.8 ± 0.6 +C, p = 0.001). DTmax was associated with 6- and 24-h induction of serum IP-10 and of PBMC ISG expression, but only in patients with rs12979860CC [corrected].ΔTmax weakly predicted early virological response (AUC=0.68, CI 0.49-0.88).
Temperature rise following peginterferon injection is closely associated with virological response and is modulated by IL28B polymorphism, reflecting host interferon-responsiveness.
慢性丙型肝炎的干扰素治疗与发热等非特异性症状相关。我们旨在确定体温变化与干扰素抗病毒活性的关系。
60 例初治慢性丙型肝炎患者(67%基因型 1/4/6,33%基因型 2/3)入组一项临床试验开始接受聚乙二醇干扰素 alfa-2a 和利巴韦林治疗。在最初 24 小时内,在基线和每日 3 次测量体温,并确定这段时间内的最大体温升高(ΔTmax)。在非常早期时间点测量外周血单个核细胞(PBMC)中的血清 HCV-RNA、干扰素-γ诱导蛋白-10(IP-10)和干扰素刺激基因(ISGs - CD274、ISG15、RSAD2、IRF7、CXCL10)的表达,并计算反应动力学。对 IL28B 单核苷酸多态性 rs12979860 进行基因分型。
体温升高 1.2±0.8°C,在 12.5 小时时达到峰值。ΔTmax 与第 1 相病毒学下降呈强烈相关(r=0.59,p<0.0001),与性别、肝硬化、病毒基因型或基线 HCV-RNA 无关。rs12979860CC 基因型患者中观察到与第 1 相下降的相关性(r = 0.65,p <0.0001),而 CT/TT 基因型患者中无相关性(r = 0.13,p = 0.53),且 CC 基因型患者的 DTmax 更高(1.4 ± 0.8°C 比 0.8 ± 0.6°C,p = 0.001)。DTmax 与血清 IP-10 和 PBMC ISG 表达的 6 小时和 24 小时诱导相关,但仅在 rs12979860CC 患者中相关[校正]。ΔTmax 对早期病毒学应答有弱预测作用(AUC=0.68,CI 0.49-0.88)。
聚乙二醇干扰素注射后体温升高与病毒学应答密切相关,并受 IL28B 多态性调节,反映宿主干扰素反应性。